SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice WildingJohn FernandoKevin MilneNicola EvansMarc AliAmar BainSteve JamesJune Newland-JonesPhilip PatelDipesh ViljoenAdie 2020 <p></p><p> </p><p><strong>Article full text</strong></p><p><br> The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.</p><p><br> The above features represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p><p>© The authors, CC-BY-NC 2020.</p><p><br></p><p><br></p><p> </p><p></p>